2020
DOI: 10.1093/qjmed/hcaa070.016
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of Intra-Detrusor Injection of Botulinum A Toxin in Neurogenic Bladder in Patients with Multiple Sclerosis

Abstract: Background Early diagnosis and amelioration of lower urinary tract symptoms is a key focus in the management of multiple sclerosis. Untreated LUTS can lead to increased morbidity and mortality, for instance as a result of irreversible changes in the lower urinary tract itself, recurrent UTIs, renal stones, renal function impairment, and lowered HR-QoL. Aim of the Work to assess the effects of intradetrusor muscle injection of… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles